135 related articles for article (PubMed ID: 15077196)
1. Role of PLZF in melanoma progression.
Felicetti F; Bottero L; Felli N; Mattia G; Labbaye C; Alvino E; Peschle C; Colombo MP; Carè A
Oncogene; 2004 Jun; 23(26):4567-76. PubMed ID: 15077196
[TBL] [Abstract][Full Text] [Related]
2. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
3. HOXB7: a key factor for tumor-associated angiogenic switch.
Carè A; Felicetti F; Meccia E; Bottero L; Parenza M; Stoppacciaro A; Peschle C; Colombo MP
Cancer Res; 2001 Sep; 61(17):6532-9. PubMed ID: 11522651
[TBL] [Abstract][Full Text] [Related]
4. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation.
Kikugawa T; Kinugasa Y; Shiraishi K; Nanba D; Nakashiro K; Tanji N; Yokoyama M; Higashiyama S
Prostate; 2006 Jul; 66(10):1092-9. PubMed ID: 16637071
[TBL] [Abstract][Full Text] [Related]
5. PLZF-mediated control on VLA-4 expression in normal and leukemic myeloid cells.
Quaranta MT; Spinello I; Testa U; Mariani G; Diverio D; Foà R; Peschle C; Labbaye C
Oncogene; 2006 Jan; 25(3):399-408. PubMed ID: 16158049
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
[TBL] [Abstract][Full Text] [Related]
7. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells.
Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF
Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells.
Briggs J; Chamboredon S; Castellazzi M; Kerry JA; Bos TJ
Oncogene; 2002 Oct; 21(46):7077-91. PubMed ID: 12370830
[TBL] [Abstract][Full Text] [Related]
9. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
10. A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis.
Rho SB; Park YG; Park K; Lee SH; Lee JH
FEBS Lett; 2006 Jul; 580(17):4073-80. PubMed ID: 16828757
[TBL] [Abstract][Full Text] [Related]
11. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF.
Chauchereau A; Mathieu M; de Saintignon J; Ferreira R; Pritchard LL; Mishal Z; Dejean A; Harel-Bellan A
Oncogene; 2004 Nov; 23(54):8777-84. PubMed ID: 15467736
[TBL] [Abstract][Full Text] [Related]
12. PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein.
Labbaye C; Quaranta MT; Pagliuca A; Militi S; Licht JD; Testa U; Peschle C
Oncogene; 2002 Sep; 21(43):6669-79. PubMed ID: 12242665
[TBL] [Abstract][Full Text] [Related]
13. Osteonectin/SPARC induction by ectopic beta(3) integrin in human radial growth phase primary melanoma cells.
Sturm RA; Satyamoorthy K; Meier F; Gardiner BB; Smit DJ; Vaidya B; Herlyn M
Cancer Res; 2002 Jan; 62(1):226-32. PubMed ID: 11782382
[TBL] [Abstract][Full Text] [Related]
14. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo targeting of gene expression to melanoma cells.
Vile RG; Hart IR
Cancer Res; 1993 Mar; 53(5):962-7. PubMed ID: 8439971
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
[TBL] [Abstract][Full Text] [Related]
17. The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
Felicetti F; Errico MC; Bottero L; Segnalini P; Stoppacciaro A; Biffoni M; Felli N; Mattia G; Petrini M; Colombo MP; Peschle C; Carè A
Cancer Res; 2008 Apr; 68(8):2745-54. PubMed ID: 18417445
[TBL] [Abstract][Full Text] [Related]
18. The promyelocytic leukemia zinc finger protein down-regulates apoptosis and expression of the proapoptotic BID protein in lymphocytes.
Parrado A; Robledo M; Moya-Quiles MR; Marín LA; Chomienne C; Padua RA; Alvarez-López MR
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1898-903. PubMed ID: 14769944
[TBL] [Abstract][Full Text] [Related]
19. SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
[TBL] [Abstract][Full Text] [Related]
20. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
